• 1
    Balistreri WF. Neonatal cholestasis—medical progress. J Pediatr 1985; 106: 171184.
  • 2
    Otte JB, de Ville de Goyet J, Reding R, Hausleithner V, Sokal E, Chardot C, Debande B. Sequential treatment of biliary atresia with Kasai portoenterostomy and liver transplantation: a review. Hepatology 1994; 20(suppl): 41S48S.
  • 3
    Schweizer P. Treatment of extrahepatic bile duct atresia: results and long-term prognosis after hepatic portoenterostomy. Pediatr Surg Int 1986; 1: 3036.
  • 4
    Desmet VJ. Congenital diseases of intrahepatic bile ducts: variation on the theme “Ductal Plate Malformation.” Hepatology 1992; 16: 10691083.
  • 5
    Kasai M. Treatment of biliary atresia with special reference to hepatic portoenterostomy and its modifications. Prog Pediatr Surg 1974; 6: 552.
  • 6
    Kasai M, Mochizuki I, Ohkohchi N, Chiba T, Ohi R. Surgical limitations for biliary atresia: indication for liver transplantation. J Pediatr Surg 1989; 24: 851854.
  • 7
    Laurent J, Gauthier F, Bernard O, Hadchouel M, Odievre M, Valayer J, Alagille D, et al. Long-term outcome after surgery for biliary atresia: study of 40 patients surviving for more than 10 years. Gastroenterology 1990; 99: 17931797.
  • 8
    Grosfeld JL, Fitzgerald JF, Predaina R, West KW, Vane DW, Rescorla FJ. The efficacy of hepatoportoenterostomy in biliary atresia. Surgery 1989; 106: 692701.
  • 9
    Miyano T, Fujimoto T, Ohya T, Shimomura H. Current concept of treatment of biliary atresia. World J Surg 1993; 17: 332336.
  • 10
    Ohi R, Nio M, Chiba T, Endo N, Goto M, Ibrahim M. Long-term follow-up after surgery for patients with biliary atresia. J Pediatr Surg 1990; 25: 442445.
  • 11
    Tan CEL, Davenport M, Driver M, Howard ER. Does the morphology of the extrahepatic biliary remnants in biliary atresia influence survival? A review of 205 cases. J Pediatr Surg 1994; 29: 14591464.
  • 12
    Chandra RS, Altman RP. Ductal remnants in extrahepatic biliary atresia: a histopathologic study with clinical correlation. J Pediatr 1978; 93: 196200.
  • 13
    Schweizer P. Extrahepatic biliary atresia—an analytic assessment of prognostic factors. Contribution to a rational therapeutic approach. Zeitschrift fur Kinderchirurgie 1990; 45: 365370.
  • 14
    Whitington PF, Balistreri WF. Liver transplantation in pediatrics: indications, contraindications, and pre-transplant management. J Pediatr 1991; 118: 169177.
  • 15
    Howard ER. Extrahepatic biliary atresia—a review of current management. Br J Surg 1983; 70: 193197.
  • 16
    Mieli-Vergani G, Howard ER, Portman B, Mowat AP. Late referral for biliary atresia—missed opportunities for effective surgery. Lancet 1989; 1: 421423.
  • 17
    Mowat AP, Davidson LL, Dick MC. Earlier identification of biliary atresia and hepatobiliary disease: selective screening in the third week of life. Arch Dis Child 1995; 72: 9092.
  • 18
    Hays DM, Kimura K. Biliary atresia, the Japanese experience. Cambridge, London: Harvard University Press, 1980.
  • 19
    Smith BM, Laberge JM, Schreiber R, Weber AM, Blanchard H. Familial biliary atresia in three siblings including twins. J Pediatr Surg 1991; 26: 13311333.
  • 20
    Moore TC, Hyman PE. Extrahepatic biliary atresia in one human leukocyte antigen identical twin. Pediatrics 1985; 76: 604605.
  • 21
    Werlin S. Extrahepatic biliary atresia in one of twins. Acta Paediatr 1981; 70: 943.
  • 22
    Landing BH. Consideration of the pathogenesis of neonatal hepatitis, biliary atresia and choledochal cyst—the concept of infantile obstructive cholangiopathy. Prog Pediatr Surg 1975; 6: 113.
  • 23
    Silveira TR, Salzano FM, Donaldson PT, Mieli-Vergani G, Howard ER, Mowat AP. Association between HLA and extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr 1993; 16: 114117.
  • 24
    Schreiber RA, Kleinman RE. Genetics, immunology, and biliary atresia: an opening or a diversion? [editorial]. J Pediatr Gastroenterol Nutr 1993; 16: 111113.
  • 25
    Carmi R, Magee CA, Neill CA, Karrer FM. Extrahepatic biliary atresia and associated anomalies: etiologic heterogeneity suggested by distinctive patterns of associations. Am J Med Genet 1993; 45: 683693.
  • 26
    Davenport M, Savage M, Mowat AP, Howard ER. Biliary atresia splenic malformation syndromes: an etiologic and prognostic subgroup. Surgery 1993; 113: 662668.
  • 27
    Gautier M, Eliot N. Extrahepatic biliary atresia. Morphological study of 98 biliary remnants. Arch Pathol Lab Med 1981; 105: 397402.
  • 28
    Raweily EA, Gibson AAM, Burt AD. Abnormalities of intrahepatic bile ducts in extrahepatic biliary atresia. Histopathology 1990; 17: 521527.
  • 29
    Tan CE, Driver M, Howard ER, Moscosco GJ. Extrahepatic biliary atresia: a first-trimester event? Clues from light microscopy and immunohistochemistry. J Pediatr Surg 1994; 29: 808814.
  • 30
    Tan CEL, Moscoso GJ. The developing human biliary system at the porta hepatic level between 29 days and 8 weeks of gestation— a way to understanding biliary atresia. Part I. Pathology International 1994; 44: 587599.
  • 31
    Tan CE, Moscoso GJ. The developing human biliary system at the porta hepatic level between 11 and 25 weeks of gestation: a way to understanding biliary atresia. Part II. Pathology International 1994; 44: 600610.
  • 32
    Haber B, Naji L, Cressman D, Taub R. Coexpression of liverspecific and growth-induced genes in perinatal and regenerating liver: attainment and maintenance of the differentiated state during rapid proliferation. Hepatology 1995; 22: 906914.
  • 33
    Sanzen T, Yoshida K, Sasaki M, Terada T, Nakanuma Y. Expression of glycoconjugates during intrahepatic bile duct development in the rat: an immunohistochemical and lectin-histochemical study. Hepatology 1995; 22: 944951.
  • 34
    National Institutes of Health Consensus Development Conference Statement: Liver Transplantation —June 20-23,1983. Hepatology 1984; 4(suppl): 107S110S.
  • 35
    Ohi R, Hanamatsu M, Mochizuki I, Chiba T, Kasai M. Progress in the treatment of biliary atresia. World J Surg 1985; 9: 285293.
  • 36
    Ohi R, Shikes RH, Stellin GP, Lilly JR. In biliary atresia duct histology correlates with bile flow. J Pediatr Surg 1984; 19: 467470.
  • 37
    Falchetti D, de Carvalho FB, Clapuyt P, de Ville de Goyet J, de Hemptinne B, Glaus D, Otte JB. Liver transplantation in children with biliary atresia and polysplenia syndrome. J Pediatr Surg 1991; 26: 528531.
  • 38
    Miyano T, Ohya T, Kimura K. Indications for the Kasai operation: experience with 103 Suruga II modifications. Pediatr Surg Int 1990; 5: 8286.
  • 39
    Ryckman F, Fisher R, Pedersen S, Dittrich V, Heubi J, Farrell M, Balistreri W, et al. Improved survival in biliary atresia patients in the present era of liver transplantation. J Pediatr Surg 1993; 28: 382386.
  • 40
    Broelsch CE, Emond JC, Whitington PF. Application of reducedsize liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg 1990; 212: 368377.
  • 41
    Kalayoglu M, Stratta RJ, Sollinger HW, Hoffmann RM, D'Alessandro AM, Pirsch JD, Belzer FO. Liver transplantation in infants and children. J Pediatr Surg 1989; 24: 7076.
  • 42
    Danks D, Bodian M. A genetic study of neonatal obstructive jaundice. Arch Dis Child 1963; 38: 378390.
  • 43
    Strickland AD, Shannon K. Studies in the etiology of extrahepatic biliary atresia: time-space clustering. J Pediatr 1982; 100: 749753.
  • 44
    Morecki R, Glaser JH, Cho S, Balistreri WF, Horwitz MS. Biliary atresia and reovirus type 3 infection. N Engl J Med 1982; 307: 481.
  • 45
    Morecki R, Glaser JH, Johnson AB, Kress Y. Detection of reovirus type 3 in the porta hepatis of an infant with extrahepatic biliary atresia: ultrastructural and immunocytochemical study. Hepatology 1984; 4: 1137.
  • 46
    Phillips PA, Keast D, Papadimitiau JM, Walters MN-I, Stanley NF. Chronic obstructive jaundice induced by reovirus type 3 in weanling mice. Pathology 1969; 1: 193203.
  • 47
    Bangaru B, Morecki R, Glaser JH, Gartner LM, Horwitz MS. Comparative studies of biliary atresia in the human newborn and reovirus-induced cholangitis in weanling mice. Lab Invest 1980; 43: 456462.
  • 48
    Dussaix E, Hadchouel M, Tardieu M, Alagille D. Biliary atresia and reovirus type 3 infection. N Engl J Med 1984; 310: 658.
  • 49
    Brown WR, Sokol RJ, Levin MJ, Silverman A, Tamaru T, Lilly JR, Hall RJ, et al. Lack of correlation between infection with reovirus 3 and extrahepatic biliary atresia or neonatal hepatitis. J Pediatr 1988; 113: 670676.
  • 50
    Steele MI, Marshall CM, Lloyd RE, Randolph VE. Reovirus 3 not detected by reverse transcriptase—mediated polymerase chain reaction analysis of preserved tissue from infants with cholestatic liver disease. Hepatology 1995; 21: 697702.
  • 51
    Taterka J, Sutcliffe M, Rubin DH. Selective reovirus infection of murine hepatocarcinoma cells during cell division: a model of viral disease. J Clin Invest 1994; 94: 353360.
  • 52
    Riepenhoff-Talty M, Shaekel K, Clark HF, Mueller W, Uhnoo I, Rossi T, Fisher J, et al. Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice. Pediatr Res 1993; 33: 394399.
  • 53
    Riepenhoff-Talty M, Gouvea V, Ruffm D, Barrett H, Rossi T. Group C rotavirus: one possible cause of extrahepatic biliary atresia in human infants [Abstract]. Pediatr Res 1992; 31: 115A.
  • 54
    Hart MH, Kaufman SS, Vanderhoof JA, Erdman L, Linder J, Markin RS, Kruger R, et al. Neonatal hepatitis and extrahepatic biliary atresia associated with cytomegalovirus infection in twins. Am J Dis Child 1991; 145: 302305.
  • 55
    Chang M-H, Huan H-H, Huan E-S, Kao C-L, Husi H-Y, Lee C-Y. Polymerase chain reaction to detect human cytomegalovirus in livers of infants with neonatal hepatitis. Gastroenterology 1992; 103: 10221025.
  • 56
    Harper P, Plant JW, Linger DB. Congenital biliary atresia and jaundice in lambs and calves. Aust Vet J 1990; 67: 1822.
  • 57
    Yokoyama T, Copeland NG, Jenkins NA, Montgomery CA, Elder FFB, Overbeek PA. Reversal of left-right asymmetry: a situs inversus mutation. Science 1993; 260: 679682.
  • 58
    Brueckner M, D'Eustachio P, Horwich AL. Linkage mapping of a mouse gene, iv, that controls left-right asymmetry of the heart and viscera. Proc Natl Acad Sci U S A 1989; 86: 50355038.
  • 59
    Hanzlik AJ, Binder M, Layton WM, Rowe L, Layton M, Taylor BA, Osemlak MM, et al. The murine situs inversus viscerum gene responsible for visceral asymmetry is linked tightly to the Igh-C cluster on chromosome 12. Genomics 1990; 7: 389393.
  • 60
    Van der Hoeven F, Volkmann A, Mattel M-G, Kyewski B, Ruther U. Programmed cell death is affected in the novel mouse mutant fused toes (Ft). Development 1994; 1: 26012607.
  • 61
    Afzelius BA, Mossberg B. Immotile-cilia syndrome (primary ciliary dyskinesia), including Kartagener syndrome. In: ScriverCR, BeaudetAL, SlyWS, ValleD., eds. The Metabolic basis of inherited disease. New York: McGraw-Hill, 1989: 27392750.
  • 62
    Casey B, Cevoto M, Jones KL, Ballabio A. Mapping a gene for familial situs abnormalities to human chromosome Xq24-127.1. Nat Genet 1993; 5: 403407.
  • 63
    Sklar AJS. A model for specification of the left-right axis in vertebrates. Trends Genet 1994; 10: 392396.
  • 64
    Roberts CWM, Shutter JR, Korsmeyer SJ. Hox 11 controls the genesis of the spleen. Nature 1994; 368: 747749.
  • 65
    Rosen EM, Nigam SK, Goldberg ID. Scatter factor and the c-Met receptor: a paradigm for mesenchymal/epithelial interaction. J Cell Biol 1994; 127: 17831787.
  • 66
    Tsarfaty I, Resau JH, Rulong S, Keydar I, Faletto DL, Van de Woude GF. The met proto-oncogene receptor and lumen formation. Science 1992; 257: 12581261.
  • 67
    Tsarfaty I, Rong S, Resau JH, Rulong S, Pinto de Silva P, Van de Woude GF. The met proto-oncogene mesenchymal to epithelial cell conversion. Science 1994; 263: 98101.
  • 68
    Sonnenberg E, Meyer D, Weidner KM, Birchmeier C. Scatter factor/hepatocyte growth factor and its receptor, the c-Met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J Cell Biol 1993; 123: 223235.
  • 69
    Huff JL, Jelinek MA, Borgman CA, Lansing TJ, Parsons JT. The proto-oncogene c-Sea encodes a transmembrane protein-tyrosine kinase related to the Met/hepatocyte growth factor/scatter factor receptor. Proc Natl Acad Sci U S A 1993; 90: 61406144.
  • 70
    Stamatoglou SC, Enrich C, Manson MM, Hughes RC. Temporal changes in the expression and distribution of adhesion molecules during liver development and regeneration. J Cell Biol 1992; 116: 15071515.
  • 71
    Nagy P, Bisgaard HC, Thorgeirsson SS. Expression of hepatic transcription factors during liver development and oval cell differentiation. J Cell Biol 1994; 126: 223233.
  • 72
    Terada T, Nakanuma Y. Profiles of expression of carbohydrate chain structures during human intrahepatic bile duct development and maturation: A lectin-histochemical and immunohistochemical study. Hepatology 1994; 20: 388397.
  • 73
    Schreiber RA, Kleinman RE, Barksdale EM, Maganaro TF, Donahue PR. Rejection of murine congenic bile ducts: model for immune-mediated bile duct disease. Gastroenterology 1992; 102: 924930.
  • 74
    Seidman SL, Duquesnoy RJ, Zeevi A, Fung JJ, Starzl TE, Demetris AJ. Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes. Hepatology 1991; 13: 239246.
  • 75
    Dillon P, Belchis D, Tracy T, Cilley R, Hafey L, Krummel T. Increased expression of intracellular adhesion molecules in biliary atresia. Am J Pathol 1994; 145: 263267.
  • 76
    Ho C-W, Shioda K, Shirasaki K, Takahashi S, Tokimatsu S, Maedia K. The pathogenesis of biliary atresia: a morphological study of the hepatobiliary system and the hepatic artery. J Pediatr Gastroenterol Nutr 1993; 16: 5360.
  • 77
    Vierling J, Hu K-Q. Immunologic mechanisms of hepatobiliary injury. In: KaplowitzN, ed. Liver and biliary diseases. Baltimore: Williams and Wilkins, 1992: 4869.
  • 78
    Friedman SL, Roll FJ, Boyles J, Bissel DM. Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci U S A 1985; 82: 86818685.
  • 79
    Brenner DB, Alcorn JM. Pathogenesis of hepatic fibrosis. In: KaplowitzN, ed. Liver and biliary diseases. Baltimore: Williams and Wilkins, 1992: 118130.
  • 80
    Malizia G, Brunt EM, Peters MG, Rizzi A, Broedelmann TJ, McDonald JA. Growth factor and procollagen type I gene expression in human liver disease. Gastroenterology 1995; 108: 145156.
  • 81
    Friedman SL. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993; 328: 18281835.
  • 82
    Sokol RJ, Devereaux M, Khandwala T, O'Brien K. Evidence for involvement of oxygen free radicals in bile acid toxicity to isolated rat hepatocytes. Hepatology 1993; 17: 869881.
  • 83
    Sokol RJ, Winklhofer-Roob BM, Devereaux MW, Mc Kim JM Jr. Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids. Gastroenterology 1995; 109: 12491256.
  • 84
    Greim H, Trulzsch D, Gzygan P, Rudick J, Hutterer F, Schaffner F, Popper H. Mechanism of cholestasis: bile acids in human livers with or without biliary obstruction. Gastroenterology 1972; 63: 846850.
  • 85
    Hofmann AF, Popper H. Ursodeoxycholic acid for primary biliary cirrhosis. Lancet 1987; 2: 398399.
  • 86
    Patel T, Bronk SF, Gores GJ. Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in hepatocytes. J Clin Invest 1994; 94: 21832192.
  • 87
    Spivey JR, Bronk SF, Gores GJ. Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium. J Clin Invest 1993; 92: 1724.
  • 88
    Krahenbuhl S, Stucki J, Reichen J. Reduced activity of the electron transport chain in liver mitochondria isolated from rats with secondary biliary cirrhosis. Hepatology 1992; 15: 11601166.
  • 89
    Krahenbuhl S, Talos C, Fischer S, Reichen J. Toxicity of bile acids on the electron transport chain of isolated rat liver mitochondria. Hepatology 1994; 19: 471479.
  • 90
    Krahenbuhl S, Talos C, Lauterburg BH, Reichen J. Reduced antioxidative capacity in liver mitochondria from bile duct ligated rats. Hepatology 1995; 22: 607612.
  • 91
    Sokol RJ, Devereaux M, Khandwala RA. Effect of dietary lipid and vitamin E on mitochondrial lipid peroxidation and hepatic injury in the bile duct-ligated rat. J Lipid Res 1991; 32: 13491357.
  • 92
    UNOS Update 1994; 10: 37.
  • 93
    UNOS, U.S. Department of Health and Human Services. 1994 annual report of the U.S. Scientific Registry of Transplant Recipients and the Organ Procurement and Transplant Network— transplant data: 1988–1993. Richmond, VA, and Bethesda, MD: UNOS and Division of Organ Transplantation, Bureau of Health Resources Development, Health Resources and Services Administration, U.S. Department of Health and Human Services.